A post-hoc physiological analysis of fifteen critically ill patients with morbid obesity found that PSV-PEEP lowered work of ...
Resmed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended September 30, 2026. “We began fiscal year 2027 with a strong first quarter, driven by continued global demand for our ...
A strategic investor. Vivos, a Nasdaq‑listed leader in the treatment of obstructive sleep apnea, becomes an 11% shareholder in SOD Sciences, and SOD becomes a holder of Vivos convertible preferred ...
Aetherion Technologies Inc. (“Aetherion") (TSX: AETR / Nasdaq: AETR), announces that the Company will release Q3 2026 financial results on Thursday, November 12, 2026, after market close. A conference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results